Model:7501298253008
Current Reviews:0
Price:$20.10

Kaliolite 500mg 50 Caps, Potassium

THERAPEUTIC INDICATIONS:

The indications for potassium replacement therapy are:

• Hypokalemia and potassium levels below 3 mEq / l.

• arrhythmias secondary to digitalis toxicity.

• familial periodic paralysis with hypokalemia.

Potassium chloride is recommended in cases of metabolic alkalosis hypochloremic often accompanied by low potassium.

Is indicated as prophylaxis in patients at risk of hypokalemia, and those under treatment with loop diuretics or thiazides (including patients with heart failure treated with digitalis, high risk of myocardial infarction, severe liver failure and diabetes mellitus), excess aldosterone with normal renal function, nephropathy with loss of potassium, and conditions with chronic diarrhea.

Diuretic-induced hypokalemia is controlled successfully with potassium supplementation. Other causes or predisposing factors for development of hypokalemia include the administration of large amounts of glucose or insulin, gastrointestinal losses due to vomiting, nasogastric suction, and diarrhea, urinary leakage secondary to Cushing's syndrome, renal tubular acidosis and hypomagnesemia, chronic alcoholism drugs such as aminoglycosides, amphotericin B, carbenicillin, mineralocorticoid and lithium.

Hypersensitivity to the components of the formula. In patients with severe renal impairment, untreated Addison's disease, weakness inherited episodic, acute dehydration, hyperkalemia, gastrointestinal disease and delay the passage of the tablet through the gastrointestinal tract or suffering from heat cramps.

CAUTIONS: The concomitant use of potassium-sparing diuretics or ACE inhibitors, atrioventricular conduction disturbances induced by digitalis unless hypokalemia is documented and should be used with caution in patients taking salt substitutes containing potassium. It is recommended to monitor serum potassium levels to determine therapeutic efficacy.

The use of potassium salts in patients with chronic kidney disease or other condition in which there is a change in potassium excretion, requires careful monitoring of serum potassium and proper adjustment of the dose.

Hypokalemia in patients with metabolic acidosis should be treated with an alkaline salt such as potassium bicarbonate, potassium citrate, potassium acetate or potassium gluconate.

In interpreting the serum potassium level, the physician should keep in mind that acute alkalosis per se can produce hypokalemia in the absence of a deficit in total body potassium, while the acidosis per se increases the serum concentration of potassium in normal range, even in the presence of a reduction in total body potassium.

The treatment of depletion, particularly in the presence of heart disease, kidney disease, requires careful attention to acid-base balance and appropriate monitoring of serum electrolytes, electrocardiogram and clinical status.

RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION: Since its main application is potassium depletion, its use is strictly under the responsibility of the treating physician.

The normal potassium ion content in human milk is about 13 mEq / l. The potassium chloride supplements are probably little or no effect on the level in human milk.

DOSAGE AND ADMINISTRATION The usual intake of potassium from the average adult is 60 to 100 mEq per day. Potassium depletion sufficient to cause hypokalemia, usuallyrequires a loss of 200 or more mEq of potassium from total body storage.

The dosage should be adjusted according to patient needs. For prevention of hypokalemia, the dose usually is within the range of 20 mEq per day. For the treatment of potassium depletion, using dosages of 40 to 100 mEq per day or more. If you are prescribed more than one tablet of K-DUR ® (20 mEq) per day, the total daily dosage should be divided into two or more separate doses.

The tablets should be taken with a meal and a glass of water or other liquid. This product should not be taken on an empty stomach.

Patients who have difficulty swallowing the Tablets can follow one of the following alternatives:

• Break the tablet in half and take each half separately with a glass of water.

Prepare an aqueous suspension as follows: Place the tablet in half a glass of water (120 ml).Wait two to three minutes for the tablet to disintegrate. Drink the content immediately. Finally take a small amount of additional water. If younotice any excess dilution does not eat it and discard.

It is not advisable to use other liquids to make the dilution of K-DUR tablets ®. Petidas ofplasma electrolytes.

Name of medicine: Kaliolite
Comparable patent medicine: Kaliolite
Active ingredient: Potassium Chloride
Presentation: Tablets
Concentration: 500 mg
Extended-release tablets: No
Lab: MERCK, SA de CV
Box with 50 pills
Made in: Mexico